AH Limper, TV Colby, MS Sanders, S Asakura, PC Roche and RA DeRemee
Thoracic Diseases Research Unit, Mayo Clinic, Rochester, MN 55905.

Sarcoidosis is a chronic inflammatory disease of unknown cause characterized by the formation of nonnecrotizing granulomas in affected tissues, most notably the lungs. Granuloma healing may result in pulmonary fibrosis and respiratory impairment in some patients. Transforming growth factor-beta 1 (TGF-beta 1) is a potent cytokine that promotes fibrosis by enhancing the synthesis of extracellular matrix components, including fibronectin and the alpha 5 beta 1 fibronectin receptor. The role of TGF-beta 1 in promoting lung fibrosis in the setting of pulmonary sarcoidosis has not yet been investigated. Accordingly, we determined the extent and distribution of TGF-beta 1 in lung tissue obtained from seven patients with clinical and histologic features of pulmonary sarcoidosis. The tissue distributions of TGF-beta 1, the TGF-beta 1 binding proteoglycan decorin, fibronectin, and the alpha 5 beta 1 fibronectin receptor were assessed immunohistochemically. In all cases, the epithelioid histiocytes comprising nonnecrotizing granulomas of pulmonary sarcoidosis contained abundant TGF-beta 1. We further demonstrated decorin, fibronectin, and the alpha 5 beta 1 fibronectin receptor within nonnecrotizing granulomas and in the fibrous tissue surrounding the lesions. TGF-beta 1 staining was also observed in bronchiolar epithelial cells, hyperplastic Type II pneumocytes, and occasional alveolar macrophages. This study demonstrates enhanced tissue localization of TGF-beta 1 and related extracellular matrix proteins associated with the nonnecrotizing granulomas of pulmonary sarcoidosis. Through its actions on matrix protein synthesis, TGF-beta 1 may modulate the fibrotic repair process accompanying granuloma healing in sarcoidosis.

This article has been cited by other articles:

				A. Ramirez, B. Ramadan, J. D. Ritzenthaler, H. N. Rivera, D. P. Jones, and J. Roman Extracellular cysteine/cystine redox potential controls lung fibroblast proliferation and matrix expression through upregulation of transforming growth factor-beta Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L972 - L981. [Abstract] [Full Text] [PDF]

				A. C. Jonth, L. Silveira, T. E. Fingerlin, H. Sato, J. C. Luby, K. I. Welsh, C. S. Rose, L. S. Newman, R. M. du Bois, L. A. Maier, et al. TGF-beta1 Variants in Chronic Beryllium Disease and Sarcoidosis J. Immunol., September 15, 2007; 179(6): 4255 - 4262. [Abstract] [Full Text] [PDF]

				F. Chua, S. E. Dunsmore, P. H. Clingen, S. E. Mutsaers, S. D. Shapiro, A. W. Segal, J. Roes, and G. J. Laurent Mice Lacking Neutrophil Elastase Are Resistant to Bleomycin-Induced Pulmonary Fibrosis Am. J. Pathol., January 1, 2007; 170(1): 65 - 74. [Abstract] [Full Text] [PDF]

				S. E. Evans, T. V. Colby, J. H. Ryu, and A. H. Limper Transforming Growth Factor-{beta}1 and Extracellular Matrix-Associated Fibronectin Expression in Pulmonary Lymphangioleiomyomatosis Chest, March 1, 2004; 125(3): 1063 - 1070. [Abstract] [Full Text] [PDF]

				U. Bartram and C. P. Speer The Role of Transforming Growth Factor {beta} in Lung Development and Disease Chest, February 1, 2004; 125(2): 754 - 765. [Abstract] [Full Text] [PDF]

				H-P Hauber, D Gholami, A Meyer, and A Pforte Increased interleukin-13 expression in patients with sarcoidosis Thorax, June 1, 2003; 58(6): 519 - 524. [Abstract] [Full Text] [PDF]

				J. Xaus, M. Comalada, M. Cardo, A. F. Valledor, and A. Celada Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27Kip1 and p21Waf1 Blood, October 1, 2001; 98(7): 2124 - 2133. [Abstract] [Full Text] [PDF]

				S.-J. Yong, A. Adlakha, and A. H. Limper Circulating Transforming Growth Factor-{beta}1 : A Potential Marker of Disease Activity During Idiopathic Pulmonary Fibrosis Chest, July 1, 2001; 120(2007): 68S - 70S. [Full Text] [PDF]

				K. Chen, Y. Wei, G. C. Sharp, and H. Braley-Mullen Characterization of thyroid fibrosis in a murine model of granulomatous experimental autoimmune thyroiditis J. Leukoc. Biol., December 1, 2000; 68(6): 828 - 835. [Abstract] [Full Text]

				M. A. Judson An Approach to the Treatment of Pulmonary Sarcoidosis With Corticosteroids: The Six Phases of Treatment Chest, April 1, 1999; 115(4): 1158 - 1165. [Abstract] [Full Text] [PDF]

				E. LAKARI, P. PAAKKO, and V. L. KINNULA Manganese Superoxide Dismutase, but not CuZn Superoxide Dismutase, Is Highly Expressed in the Granulomas of Pulmonary Sarcoidosis and Extrinsic Allergic Alveolitis Am. J. Respir. Crit. Care Med., August 1, 1998; 158(2): 589 - 596. [Abstract] [Full Text] [PDF]

				M. L. Yu and A. H. Limper Pneumocystis carinii induces ICAM-1 expression in lung epithelial cells through a TNF-alpha -mediated mechanism Am J Physiol Lung Cell Mol Physiol, December 1, 1997; 273(6): L1103 - L1111. [Abstract] [Full Text] [PDF]

				L. S. Newman, C. S. Rose, and L. A. Maier Sarcoidosis N. Engl. J. Med., April 24, 1997; 336(17): 1224 - 1234. [Full Text] [PDF]